These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 33452316)

  • 21. Secondary metabolites produced by marine streptomyces as antibiofilm and quorum-sensing inhibitor of uropathogen Proteus mirabilis.
    Younis KM; Usup G; Ahmad A
    Environ Sci Pollut Res Int; 2016 Mar; 23(5):4756-67. PubMed ID: 26538254
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transduction of leucine auxotrophs of Proteus mirabilis to prototrophy or antibiotic resistance by P. mirabilis high frequency transducing bacteriophages.
    Coetzee JN; Krizsanovich-Williams K
    J Gen Microbiol; 1976 Feb; 92(2):369-74. PubMed ID: 768411
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of Proteus mirabilis distribution in multi-species biofilms on urinary catheters and determination of bacteria resistance to antimicrobial agents.
    Moryl M; Torzewska A; Jałmuzna P; Rózalski A
    Pol J Microbiol; 2013; 62(4):377-84. PubMed ID: 24730132
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Imipenem resistance in clinical isolates of Proteus mirabilis associated with alterations in penicillin-binding proteins.
    Neuwirth C; Siébor E; Duez JM; Péchinot A; Kazmierczak A
    J Antimicrob Chemother; 1995 Aug; 36(2):335-42. PubMed ID: 8522463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transduction of a Proteus vulgaris strain by a Proteus mirabilis bacteriophage.
    Coetzee JN
    J Gen Microbiol; 1975 Aug; 89(2):299-309. PubMed ID: 1100773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Antibacterial activity of gentamicin, tobramycin, amikacin, and sisomicin in vitro (author's transl)].
    Skalova R; Hajsig D; Babić I; Mostovac D
    Lijec Vjesn; 1978 Nov; 100(11):708-10. PubMed ID: 107386
    [No Abstract]   [Full Text] [Related]  

  • 27. Antibiofilm Effects of Epigallocatechin Gallate Against
    Li R; Zhou M; Lu J; Wei J
    Foodborne Pathog Dis; 2022 Feb; 19(2):136-142. PubMed ID: 34726503
    [No Abstract]   [Full Text] [Related]  

  • 28. [Chemobiotic sensitivity of common Gram-negative bacteria in urinary tract infections, 1981-1982].
    Mastandrea P; Delli Carri P
    Quad Sclavo Diagn; 1983 Dec; 19(4):455-62. PubMed ID: 6377362
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of Cefazolin and Meropenem in Eradication Biofilms of Clinical and Environmental Isolates of Proteus mirabilis.
    Silva S; Araújo L; Nascimento Junior JA; Silva T; Lopes AC; Correia MT; Silva M; Oliveira MB
    Curr Microbiol; 2020 Aug; 77(8):1681-1688. PubMed ID: 32300927
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sensitivity of gram-negative bacteria to six aminoglycoside antibiotics.
    Eyckmans L; Beert J
    Infection; 1977; 5(1):9-12. PubMed ID: 404254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined Application of Aminoglycosides and Ascorbic Acid in the Elimination of
    Stolarek P; Bernat P; Różalski A
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361855
    [No Abstract]   [Full Text] [Related]  

  • 32. Antibiofilm effect of Nocardiopsis sp. GRG 1 (KT235640) compound against biofilm forming Gram negative bacteria on UTIs.
    Rajivgandhi G; Vijayan R; Maruthupandy M; Vaseeharan B; Manoharan N
    Microb Pathog; 2018 May; 118():190-198. PubMed ID: 29524549
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Composition of the outer membrane of Proteus mirabilis in relation to serum sensitivity in progressive stages of cell form defectiveness.
    Siegmund-Schultze N; Kroll HP; Martin HH; Nixdorff K
    J Gen Microbiol; 1991 Dec; 137(12):2753-9. PubMed ID: 1791430
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The role of aminoglycoside--modifying enzymes in resistance of Gram-negative rods].
    Jakoniuk P; Wieczorek P; Sacha PT; Zalewska M; Leszczyńska K
    Med Dosw Mikrobiol; 2006; 58(4):363-70. PubMed ID: 17642314
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The use of lytic bacteriophages in the prevention and eradication of biofilms of Proteus mirabilis and Escherichia coli.
    Carson L; Gorman SP; Gilmore BF
    FEMS Immunol Med Microbiol; 2010 Aug; 59(3):447-55. PubMed ID: 20528927
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of D-Tyrosine combined with amikacin on the biofilms of Pseudomonas aeruginosa.
    She P; Chen L; Liu H; Zou Y; Luo Z; Koronfel A; Wu Y
    Microb Pathog; 2015 Sep; 86():38-44. PubMed ID: 26188263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Dynamics of drug resistance in Proteus mirabilis cultures 1970-1985].
    Shvidenko IG
    Antibiot Khimioter; 1988 Apr; 33(4):294-7. PubMed ID: 3291802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outer Membrane Disruption Overcomes Intrinsic, Acquired, and Spontaneous Antibiotic Resistance.
    MacNair CR; Brown ED
    mBio; 2020 Sep; 11(5):. PubMed ID: 32963002
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Control of emergence of multi-resistant gram-negative bacilli by exclusive use of amikacin.
    Ruiz-Palacios GM; Ponce de Leon S; Sifuentes J; Ponce de Leon S; Calva JJ; Huazano F; Ontiveros C; Ojeda F; Bobadilla M
    Am J Med; 1986 Jun; 80(6B):71-5. PubMed ID: 3089006
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Current status of aminoglycoside resistance in hospital Enterobacteriaceae].
    Ronco E; Migueres ML; Vacheron F; Guenounou M
    Pathol Biol (Paris); 1988 May; 36(5):430-4. PubMed ID: 3043339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.